D-Index & Metrics Best Publications
Giorgio Walter Canonica

Giorgio Walter Canonica

Immunology
Italy
2023
Medicine
Italy
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 109 Citations 58,697 860 World Ranking 288 National Ranking 5
Medicine D-index 109 Citations 59,403 950 World Ranking 3322 National Ranking 80

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Italy Leader Award

2023 - Research.com Immunology in Italy Leader Award

2022 - Research.com Immunology in Italy Leader Award

2018 - Member of Academia Europaea

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Asthma
  • Disease

His main research concerns Allergy, Immunology, Asthma, Intensive care medicine and Internal medicine. Particularly relevant to Allergen immunotherapy is his body of work in Allergy. His studies in Asthma integrate themes in fields like Surgery, MEDLINE, Quality of life, Family medicine and Disease.

His Intensive care medicine study integrates concerns from other disciplines, such as Sublingual immunotherapy, Postmarketing surveillance, Adverse effect, Quality of life and Alternative medicine. His work on Clinical trial and Clinical endpoint as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. As a part of the same scientific study, Giorgio Walter Canonica usually deals with the Randomized controlled trial, concentrating on Pharmacotherapy and frequently concerns with Physical therapy.

His most cited work include:

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) (3245 citations)
  • Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE (833 citations)
  • The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. (722 citations)

What are the main themes of his work throughout his whole career to date?

Immunology, Asthma, Allergy, Internal medicine and Intensive care medicine are his primary areas of study. Allergen, Immunotherapy, Immunoglobulin E, Inflammation and Allergic inflammation are the primary areas of interest in his Immunology study. His Asthma study incorporates themes from Clinical trial, MEDLINE, Adverse effect, Family medicine and Disease.

His work on Allergen immunotherapy as part of general Allergy research is often related to Slit, thus linking different fields of science. His work deals with themes such as Gastroenterology, Placebo and Endocrinology, which intersect with Internal medicine. His Intensive care medicine research is multidisciplinary, incorporating elements of Alternative medicine, COPD and Quality of life.

He most often published in these fields:

  • Immunology (40.74%)
  • Asthma (39.84%)
  • Allergy (29.97%)

What were the highlights of his more recent work (between 2018-2021)?

  • Asthma (39.84%)
  • Internal medicine (19.30%)
  • Intensive care medicine (16.84%)

In recent papers he was focusing on the following fields of study:

Giorgio Walter Canonica mainly investigates Asthma, Internal medicine, Intensive care medicine, Allergy and Severe asthma. His research in Asthma intersects with topics in Family medicine, Gastroenterology and MEDLINE. Giorgio Walter Canonica has researched Intensive care medicine in several fields, including Allergen immunotherapy, mHealth, Disease and Quality of life.

His research integrates issues of Allergists, Pharmacotherapy, Pandemic and Atopic dermatitis in his study of Allergen immunotherapy. His Allergy research entails a greater understanding of Immunology. The study incorporates disciplines such as Corticosteroid, Clinical trial and Medical history in addition to Adverse effect.

Between 2018 and 2021, his most popular works were:

  • Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. (63 citations)
  • EUFOREA consensus on biologics for CRSwNP with or without asthma (56 citations)
  • 2019 ARIA Care pathways for allergen immunotherapy (54 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Asthma

His scientific interests lie mostly in Asthma, Internal medicine, Intensive care medicine, Adverse effect and Allergy. His studies deal with areas such as Integrated care, Family medicine, COPD, Severity of illness and Cohort as well as Asthma. His Family medicine research is multidisciplinary, incorporating perspectives in Psychological intervention and MEDLINE.

He has included themes like mHealth, Disease, Review article, Atopic dermatitis and Chronic rhinosinusitis in his Intensive care medicine study. The Adverse effect study combines topics in areas such as Clinical endpoint, Clinical trial, Sarilumab, Placebo and Corticosteroid. His Allergy study is focused on Immunology in general.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)

7758 Citations

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg.
Allergy (2008)

6493 Citations

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan L. Brożek;Jean Bousquet;Ioana Agache;Arnav Agarwal.
The Journal of Allergy and Clinical Immunology (2017)

2189 Citations

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

M. Humbert;R. Beasley;J. Ayres;R. Slavin.
Allergy (2005)

1395 Citations

Consensus statement * on the treatment of allergic rhinitis

P van Cauwenberge;C Bachert;G Passalacqua;J Bousquet.
Allergy (2000)

948 Citations

Practical guide to skin prick tests in allergy to aeroallergens

J. Bousquet;J. Bousquet;L. Heinzerling;C. Bachert;N. G. Papadopoulos.
Allergy (2012)

741 Citations

Standards for practical allergen-specific immunotherapy

E. Alvarez-Cuesta;J. Bousquet;G. W. Canonica;S. R. Durham.
Allergy (2006)

720 Citations

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

Canonica Gw;Bousquet J;Casale T;Lockey Rf.
Allergy (2009)

675 Citations

Allergen immunotherapy: therapeutic vaccines for allergic diseases

J. Bousquet;R. Lockey;H.J. Malling;E. Alvarez-Cuesta.
Annals of Allergy Asthma & Immunology (1998)

649 Citations

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert;Claus Bachert;Joseph K Han;Martin Desrosiers;Peter W Hellings.
The Lancet (2019)

637 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Giorgio Walter Canonica

Jean Bousquet

Jean Bousquet

Grenoble Alpes University

Publications: 322

Pascal Demoly

Pascal Demoly

University of Montpellier

Publications: 240

Giorgio Ciprandi

Giorgio Ciprandi

University of Genoa

Publications: 232

Marcus Maurer

Marcus Maurer

Charité - University Medicine Berlin

Publications: 198

Claus Bachert

Claus Bachert

Ghent University

Publications: 198

Ludger Klimek

Ludger Klimek

Ghent University

Publications: 145

Peter Hellings

Peter Hellings

KU Leuven

Publications: 136

Torsten Zuberbier

Torsten Zuberbier

Charité - University Medicine Berlin

Publications: 122

Moises A. Calderon

Moises A. Calderon

Imperial College London

Publications: 118

Cezmi A. Akdis

Cezmi A. Akdis

University of Zurich

Publications: 117

Stephen R. Durham

Stephen R. Durham

Imperial College London

Publications: 113

Nikolaos G. Papadopoulos

Nikolaos G. Papadopoulos

National and Kapodistrian University of Athens

Publications: 112

Graham Roberts

Graham Roberts

University of Southampton

Publications: 100

Thomas B. Casale

Thomas B. Casale

University of South Florida

Publications: 99

Rudolf Valenta

Rudolf Valenta

Medical University of Vienna

Publications: 95

Giovanni Passalacqua

Giovanni Passalacqua

University of Genoa

Publications: 94

Trending Scientists

Laurenz Wiskott

Laurenz Wiskott

Ruhr University Bochum

Bradley E. Marshall

Bradley E. Marshall

Amazon (United States)

Nicholas J. Ekins-Daukes

Nicholas J. Ekins-Daukes

University of New South Wales

Wei-Chiang Hong

Wei-Chiang Hong

Asia Eastern University of Science and Technology

Craig M. Brown

Craig M. Brown

National Institute of Standards and Technology

Pierre Villeneuve

Pierre Villeneuve

Montpellier SupAgro

Qingliang Liao

Qingliang Liao

University of Science and Technology Beijing

Carl D. Sayer

Carl D. Sayer

University College London

Urs Feller

Urs Feller

University of Bern

Bianca Zingales

Bianca Zingales

Universidade de São Paulo

Rudy A. Hartskeerl

Rudy A. Hartskeerl

Royal Tropical Institute

Keith D. Wilkinson

Keith D. Wilkinson

Emory University

Roland Foisner

Roland Foisner

Medical University of Vienna

Melly S. Oitzl

Melly S. Oitzl

University of Amsterdam

Kirsten Ohm Kyvik

Kirsten Ohm Kyvik

University of Southern Denmark

Jet-Efda Contributors

Jet-Efda Contributors

International Atomic Energy Agency

Something went wrong. Please try again later.